113 related articles for article (PubMed ID: 21840596)
1. Cooperation between somatic Ikaros and Notch1 mutations at the inception of T-ALL.
Sontani Y; Chapman G; Papathanasiou P; Dunwoodie S; Goodnow CC; Hoyne GF
Leuk Res; 2011 Nov; 35(11):1512-9. PubMed ID: 21840596
[TBL] [Abstract][Full Text] [Related]
2. Ikaros regulates Notch target gene expression in developing thymocytes.
Chari S; Winandy S
J Immunol; 2008 Nov; 181(9):6265-74. PubMed ID: 18941217
[TBL] [Abstract][Full Text] [Related]
3. Ikaros is a critical target during simultaneous exposure to X-rays and N-ethyl-N-nitrosourea in mouse T-cell lymphomagenesis.
Hirano S; Kakinuma S; Amasaki Y; Nishimura M; Imaoka T; Fujimoto S; Hino O; Shimada Y
Int J Cancer; 2013 Jan; 132(2):259-68. PubMed ID: 22684892
[TBL] [Abstract][Full Text] [Related]
4. Oncogenic activation of the Notch1 gene by deletion of its promoter in Ikaros-deficient T-ALL.
Jeannet R; Mastio J; Macias-Garcia A; Oravecz A; Ashworth T; Geimer Le Lay AS; Jost B; Le Gras S; Ghysdael J; Gridley T; Honjo T; Radtke F; Aster JC; Chan S; Kastner P
Blood; 2010 Dec; 116(25):5443-54. PubMed ID: 20829372
[TBL] [Abstract][Full Text] [Related]
5. SCL, LMO1 and Notch1 reprogram thymocytes into self-renewing cells.
Gerby B; Tremblay CS; Tremblay M; Rojas-Sutterlin S; Herblot S; Hébert J; Sauvageau G; Lemieux S; Lécuyer E; Veiga DF; Hoang T
PLoS Genet; 2014 Dec; 10(12):e1004768. PubMed ID: 25522233
[TBL] [Abstract][Full Text] [Related]
6. The impact of NOTCH1, FBW7 and PTEN mutations on prognosis and downstream signaling in pediatric T-cell acute lymphoblastic leukemia: a report from the Children's Oncology Group.
Larson Gedman A; Chen Q; Kugel Desmoulin S; Ge Y; LaFiura K; Haska CL; Cherian C; Devidas M; Linda SB; Taub JW; Matherly LH
Leukemia; 2009 Aug; 23(8):1417-25. PubMed ID: 19340001
[TBL] [Abstract][Full Text] [Related]
7. Notch1 inhibition targets the leukemia-initiating cells in a Tal1/Lmo2 mouse model of T-ALL.
Tatarek J; Cullion K; Ashworth T; Gerstein R; Aster JC; Kelliher MA
Blood; 2011 Aug; 118(6):1579-90. PubMed ID: 21670468
[TBL] [Abstract][Full Text] [Related]
8. Deletion-based mechanisms of Notch1 activation in T-ALL: key roles for RAG recombinase and a conserved internal translational start site in Notch1.
Ashworth TD; Pear WS; Chiang MY; Blacklow SC; Mastio J; Xu L; Kelliher M; Kastner P; Chan S; Aster JC
Blood; 2010 Dec; 116(25):5455-64. PubMed ID: 20852131
[TBL] [Abstract][Full Text] [Related]
9. Notch activation is an early and critical event during T-Cell leukemogenesis in Ikaros-deficient mice.
Dumortier A; Jeannet R; Kirstetter P; Kleinmann E; Sellars M; dos Santos NR; Thibault C; Barths J; Ghysdael J; Punt JA; Kastner P; Chan S
Mol Cell Biol; 2006 Jan; 26(1):209-20. PubMed ID: 16354692
[TBL] [Abstract][Full Text] [Related]
10. Activated Notch counteracts Ikaros tumor suppression in mouse and human T-cell acute lymphoblastic leukemia.
Witkowski MT; Cimmino L; Hu Y; Trimarchi T; Tagoh H; McKenzie MD; Best SA; Tuohey L; Willson TA; Nutt SL; Busslinger M; Aifantis I; Smyth GK; Dickins RA
Leukemia; 2015 Jun; 29(6):1301-11. PubMed ID: 25655195
[TBL] [Abstract][Full Text] [Related]
11. Prognostic implications of mutations in NOTCH1 and FBXW7 in childhood T-ALL treated according to the NOPHO ALL-1992 and ALL-2000 protocols.
Fogelstrand L; Staffas A; Wasslavik C; Sjögren H; Söderhäll S; Frost BM; Forestier E; Degerman S; Behrendtz M; Heldrup J; Karrman K; Johansson B; Heyman M; Abrahamsson J; Palmqvist L
Pediatr Blood Cancer; 2014 Mar; 61(3):424-30. PubMed ID: 24424791
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic targeting of HES1 transcriptional programs in T-ALL.
Schnell SA; Ambesi-Impiombato A; Sanchez-Martin M; Belver L; Xu L; Qin Y; Kageyama R; Ferrando AA
Blood; 2015 Apr; 125(18):2806-14. PubMed ID: 25784680
[TBL] [Abstract][Full Text] [Related]
13. Glucocorticoid sensitivity of T-cell lymphoblastic leukemia/lymphoma is associated with glucocorticoid receptor-mediated inhibition of Notch1 expression.
Cialfi S; Palermo R; Manca S; Checquolo S; Bellavia D; Pelullo M; Quaranta R; Dominici C; Gulino A; Screpanti I; Talora C
Leukemia; 2013 Feb; 27(2):485-8. PubMed ID: 22846929
[No Abstract] [Full Text] [Related]
14. Ikaros represses the transcriptional response to Notch signaling in T-cell development.
Kleinmann E; Geimer Le Lay AS; Sellars M; Kastner P; Chan S
Mol Cell Biol; 2008 Dec; 28(24):7465-75. PubMed ID: 18852286
[TBL] [Abstract][Full Text] [Related]
15. Ikaros directly represses the notch target gene Hes1 in a leukemia T cell line: implications for CD4 regulation.
Kathrein KL; Chari S; Winandy S
J Biol Chem; 2008 Apr; 283(16):10476-84. PubMed ID: 18287091
[TBL] [Abstract][Full Text] [Related]
16. Activating Notch1 mutations are an early event in T-cell malignancy of Ikaros point mutant Plastic/+ mice.
Mantha S; Ward M; McCafferty J; Herron A; Palomero T; Ferrando A; Bank A; Richardson C
Leuk Res; 2007 Mar; 31(3):321-7. PubMed ID: 16870249
[TBL] [Abstract][Full Text] [Related]
17. Alternative promoter usage at the Notch1 locus supports ligand-independent signaling in T cell development and leukemogenesis.
Gómez-del Arco P; Kashiwagi M; Jackson AF; Naito T; Zhang J; Liu F; Kee B; Vooijs M; Radtke F; Redondo JM; Georgopoulos K
Immunity; 2010 Nov; 33(5):685-98. PubMed ID: 21093322
[TBL] [Abstract][Full Text] [Related]
18. Hes1 mediates the different responses of hematopoietic stem and progenitor cells to T cell leukemic environment.
Tian C; Zheng G; Cao Z; Li Q; Ju Z; Wang J; Yuan W; Cheng T
Cell Cycle; 2013 Jan; 12(2):322-31. PubMed ID: 23255132
[TBL] [Abstract][Full Text] [Related]
19. Haploinsufficiency of the c-myc transcriptional repressor FIR, as a dominant negative-alternative splicing model, promoted p53-dependent T-cell acute lymphoblastic leukemia progression by activating Notch1.
Matsushita K; Kitamura K; Rahmutulla B; Tanaka N; Ishige T; Satoh M; Hoshino T; Miyagi S; Mori T; Itoga S; Shimada H; Tomonaga T; Kito M; Nakajima-Takagi Y; Kubo S; Nakaseko C; Hatano M; Miki T; Matsuo M; Fukuyo M; Kaneda A; Iwama A; Nomura F
Oncotarget; 2015 Mar; 6(7):5102-17. PubMed ID: 25671302
[TBL] [Abstract][Full Text] [Related]
20. Modeling T-cell acute lymphoblastic leukemia induced by the SCL and LMO1 oncogenes.
Tremblay M; Tremblay CS; Herblot S; Aplan PD; Hébert J; Perreault C; Hoang T
Genes Dev; 2010 Jun; 24(11):1093-105. PubMed ID: 20516195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
